Spinal fusion using an HMG-CoA reductase inhibitor
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 9, 2006
Grant Date -
Dec 18, 2003
app pub date -
Oct 28, 2002
filing date -
Jun 13, 2002
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
An improved technique for spinal fusion including administration of an HMG-CoA reductase inhibitor to the fusion site. The HMG-CoA reductase inhibitor is preferably delivered to the site by a carrier. More preferably, the HMG-CoA reductase inhibitor is delivered to the site by a noncompressible delivery vehicle. The invention is suitable for promoting non-anatomic or heterotopic bone growth between any bony surfaces where bone growth is desired but does not naturally occur.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully